Letters Bisphosphonates and gastrointestinal cancers Authors’ reply to Abrahamsen and colleagues BMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f1518 (Published 12 March 2013) Cite this as: BMJ 2013;346:f1518 Article Related content Metrics Responses Peer review Related articles Research Exposure to bisphosphonates and risk of gastrointestinal cancers: series of nested case-control studies with QResearch and CPRD data Published: 16 January 2013; BMJ 346 doi:10.1136/bmj.f114 See more Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysis BMJ December 05, 2016, 355 i6188; DOI: https://doi.org/10.1136/bmj.i6188 Author’s reply to Dangoor and colleagues BMJ December 05, 2016, 355 i6508; DOI: https://doi.org/10.1136/bmj.i6508 One year cancer survival index rises in England BMJ December 05, 2016, 355 i6522; DOI: https://doi.org/10.1136/bmj.i6522 Patients’ “gut feelings” about symptoms should be taken seriously, say researchers BMJ November 23, 2016, 355 i6314; DOI: https://doi.org/10.1136/bmj.i6314 Abdominal pain after colonoscopy BMJ November 10, 2016, 355 i5505; DOI: https://doi.org/10.1136/bmj.i5505 Cited by... Authors' reply to Abrahamsen and colleaguesFulltext PDF
